Physician profile
Benjamin Thayne Larson
NPI 1972747988
$8,777.34
in general payments reported to CMS, 2019-2025
49 companies · $1,588 in 2025
The $1,588 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,092 · 2020: $1,308 · 2021: $596 · 2022: $807 · 2023: $1,041 · 2024: $1,346 · 2025: $1,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,944 · Education: $31.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,943.74 |
| Education | $31.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,265.24 | 2019-2020 | |
| Intuitive Surgical, INC. | $775.30 | 2020-2024 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $698.41 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $592.89 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $496.85 | 2019-2025 | Provenge |
| Cipla USA INC. | $491.91 | 2020 | |
| Janssen Biotech, INC. | $422.55 | 2019-2025 | Erleada, Balversa, Akeega |
| Astellas Pharma US INC | $373.46 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $360.39 | 2023-2025 | Orgovyx, Gemtesa |
| Biotissue Holdings INC. | $317.72 | 2022-2025 | |
| Pfizer INC. | $274.51 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $253.66 | 2019-2025 | |
| Urogen Pharma, INC. | $237.28 | 2022-2025 | Jelmyto |
| Accord Healthcare, INC. | $201.07 | 2023-2025 | |
| Medtronic, INC. | $190.78 | 2021 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $182.49 | 2022-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $175.04 | 2019-2024 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $157.78 | 2024-2025 | Trelstar, Tlando |
| Coloplast Corp | $111.92 | 2019-2023 | Speedicath |
| Antares Pharma, INC. | $111.78 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $85.80 | 2022-2023 | Keytruda, Lynparza |
| Teleflex LLC | $77.59 | 2022-2024 | Urolift |
| Urovant Sciences INC | $76.44 | 2022 | |
| Ferring Pharmaceuticals INC. | $68.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $68.24 | 2022-2024 | |
| C. R. Bard, INC. & Subsidiaries | $65.48 | 2019-2025 | Bard Urinary Drainage Bag |
| Allergan, INC. | $57.99 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $50.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $45.11 | 2023-2024 | Lynparza |
| Axonics, INC. | $44.02 | 2021-2022 | |
| Myovant Sciences INC. | $39.95 | 2022 | |
| Blue Earth Diagnostics | $38.40 | 2025 | Posluma |
| Olympus America INC. | $36.68 | 2021-2025 | Itind System |
| Boston Scientific Corporation | $33.33 | 2019-2025 | Rezum Generator |
| Amgen INC. | $31.48 | 2019 | |
| Calyxo, INC. | $28.98 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $28.54 | 2021 | |
| Laborie Medical Technologies Corp. | $23.82 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Progenics Pharmaceuticals, INC. | $23.81 | 2025 | |
| Baxter Healthcare | $21.11 | 2019 | |
| Immunitybio, INC. | $20.70 | 2024 | |
| Halozyme INC | $20.14 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $18.69 | 2023 | Seglentis |
| Tolmar Pharmaceuticals, INC. | $18.40 | 2019 | |
| Abc Home Medical Supply, INC. | $13.88 | 2025 | |
| Becton, Dickinson and Company | $13.43 | 2024 | Bard Urinary Drainage Bag |
| Integra Lifesciences Corporation | $12.80 | 2022 | |
| Bk Medical Holding Company INC. | $10.92 | 2019 | |
| Agiliti Surgical, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.